(Q22241556)

PubMed

PubMed publication ID

16227450

7 February 2023

Paul L Doering

author given names

Paul L

author last names

Doering

series ordinal

2

1 reference

PubMed

PubMed publication ID

16227450

Annals of Pharmacotherapy

7 February 2023

language of work or name

English

0 references

publication date

8 November 2005

0 references

published in

0 references

volume

39

0 references

issue

12

0 references

page(s)

2073-2079

0 references

cites work

Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity

1 reference

https://api.crossref.org/works/10.1345/APH.1E495

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1345/APH.1E495

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

20 April 2017

1 reference

https://api.crossref.org/works/10.1345/APH.1E495

Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease.

20 April 2017

1 reference

Alzheimer's associated inflammation, potential drug targets and future therapies

21 January 2018

1 reference

Free radical damage, iron, and Alzheimer's disease

21 January 2018

1 reference

Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments

21 January 2018

1 reference

Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury

21 January 2018

1 reference

Vitamin E protects nerve cells from amyloid beta protein toxicity

21 January 2018

1 reference

Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide

21 January 2018

1 reference

Evaluation of the efficacy of potential therapeutic agents at protecting against nitric oxide synthase-mediated mitochondrial damage in activated astrocytes.

21 January 2018

1 reference

Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review

21 January 2018

1 reference

Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease

21 January 2018

1 reference

Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study

21 January 2018

1 reference

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

The Clinical Dementia Rating (CDR): current version and scoring rules

21 January 2018

1 reference

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

21 January 2018

1 reference

A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group

21 January 2018

1 reference

Demographics, lifestyles, health characteristics, and dietary intake among dietary supplement users in Japan

21 January 2018

1 reference

VITamins And Lifestyle Cohort Study: Study Design and Characteristics of Supplement Users

21 January 2018

1 reference

Association of vitamin E and C supplement use with cognitive function and dementia in elderly men.

21 January 2018

1 reference

Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study

21 January 2018

1 reference

Dietary intake of antioxidants and risk of Alzheimer disease

21 January 2018

1 reference

Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease.

21 January 2018

1 reference

The number needed to treat (NNT) can be adjusted for bias when the outcome is measured with error

21 January 2018

1 reference

Vitamin E and donepezil for the treatment of mild cognitive impairment

21 January 2018

1 reference

Use of antioxidant supplements and its association with cognitive function in a rural elderly cohort: the MoVIES Project. Monongahela Valley Independent Elders Survey.

21 January 2018

1 reference

Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study

21 January 2018

1 reference

Antioxidant vitamin intake and risk of Alzheimer disease

21 January 2018

1 reference

Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial

21 January 2018

1 reference

Effectiveness of nutritional supplements on cognitive functioning in elderly persons: a systematic review

21 January 2018

1 reference

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

21 January 2018

1 reference

Diet, antioxidant status, and smoking habits in French men

21 January 2018

1 reference

7 January 2021

Vitamin E and Alzheimer disease: the basis for additional clinical trials

1 reference

7 January 2021

High-dose antioxidant supplements and cognitive function in community-dwelling elderly women

1 reference

7 January 2021

The independent association of smoking and drinking with serum beta-carotene levels among males in Miyagi, Japan

1 reference

7 January 2021

Supplement users differ from nonusers in demographic, lifestyle, dietary and health characteristics.

1 reference

7 January 2021

Dietary supplement use in the context of health disparities: cultural, ethnic and demographic determinants of use.

1 reference

7 January 2021

Dietary assessment of older Iowa women with a food frequency questionnaire: nutrient intake, reproducibility, and comparison with 24-hour dietary recall interviews

1 reference

7 January 2021

Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases

1 reference

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease

1 reference

7 January 2021

Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice.

1 reference

7 January 2021